clinical trial · NCT06075030
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
Chemotherapy Induced AnemiaAND017
brief summary
The purpose of this study is to determine the safety and efficacy of AND017 after 6 weeks of treatment in patients with cancer-related anemia who are receiving chemotherapy.
started
Dec 1, 2027
primary completion
Dec 1, 2027
completion
May 1, 2028
last updated
Feb 27, 2026
official title
A Multicenter, Randomized, Open-label Study of AND017 for the Treatment of Cancer-Related Anemia Patients Receiving Chemotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol